INOTIV, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.05 USD | -5.59% |
|
-8.37% | +10.35% |
| Mar. 19 | Inotiv, Inc. Elects Michael J. Harrington as Class III Member of the Board | CI |
| Feb. 12 | North American Morning Briefing : Stock Futures -2- | DJ |
Presentation Operator MessageOperator (Operator)Greetings. Welcome to Inotiv Inc.'s First Quar...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Inotiv, Inc. is a contract research company, which is engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DSA segment supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. The RMS segment offer access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
Calendar
2024-05-14
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.29
USD
Average target price
15.5
USD
Spread / Average Target
+261.31%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +10.35% | 111M | |
| +1.51% | 42.59B | |
| +8.57% | 40.65B | |
| +49.22% | 40.57B | |
| -12.36% | 26.77B | |
| +8.92% | 24.81B | |
| -25.13% | 18.17B | |
| +29.17% | 12.05B | |
| -3.12% | 11.7B | |
| +6.35% | 11.1B |
- Stock Market
- Equities
- NOTV Stock
- News Inotiv, Inc.
- Transcript : Inotiv, Inc., Q1 2022 Earnings Call, Feb 10, 2022
